Chemotherapeutic medications and their emergent complications
- PMID: 25060250
- DOI: 10.1016/j.emc.2014.04.006
Chemotherapeutic medications and their emergent complications
Abstract
Patients with complications of chemotherapy, either acute or chronic, are frequently encountered in the emergency department (ED). Some patients present with complaints immediately after chemotherapy administration, whereas others may show subtle, secondary signs or may have no signs or symptoms of chemotoxicity. An increased index of suspicion prompts early recognition, diagnosis, and prevention of further iatrogenic injury. This article reviews characteristic hypersensitivity reactions, typical organ system dysfunction, and treatment strategies for adult patients who present to the ED with complications after chemotherapy.
Keywords: Adverse; Chemotherapy; Complication; Emergency; Oncology.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Chemotherapeutic Medications and Their Emergent Complications.Hematol Oncol Clin North Am. 2017 Dec;31(6):995-1010. doi: 10.1016/j.hoc.2017.08.005. Hematol Oncol Clin North Am. 2017. PMID: 29078934 Review.
-
Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.Cancer Metastasis Rev. 2013 Dec;32(3-4):723-61. doi: 10.1007/s10555-013-9447-3. Cancer Metastasis Rev. 2013. PMID: 24043487 Free PMC article. Review.
-
An approach to chemotherapy-associated toxicity.Emerg Med Clin North Am. 2014 Feb;32(1):167-203. doi: 10.1016/j.emc.2013.09.002. Emerg Med Clin North Am. 2014. PMID: 24275174 Review.
-
Hypersensitivity reactions to antineoplastic agents: an overview.Anticancer Drugs. 2009 Jan;20(1):1-6. doi: 10.1097/CAD.0b013e32831961b3. Anticancer Drugs. 2009. PMID: 19342995 Review.
-
Acute reactions to chemotherapy agents.J Oncol Pharm Pract. 2006 Sep;12(3):127-9. doi: 10.1177/1078155206069163. J Oncol Pharm Pract. 2006. PMID: 17022867 Review.
Cited by
-
An Overview of Polymeric Nanoparticles-Based Drug Delivery System in Cancer Treatment.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231152083. doi: 10.1177/15330338231152083. Technol Cancer Res Treat. 2023. Retraction in: Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241276300. doi: 10.1177/15330338241276300. PMID: 36718541 Free PMC article. Retracted. Review.
-
Analysis of the efficacy and influencing factors of preoperative P-SOX neoadjuvant chemotherapy regimen for progressive gastric cancer-construction of a clinical prediction model.Cancer Med. 2023 Jun;12(12):13031-13040. doi: 10.1002/cam4.5977. Epub 2023 Apr 25. Cancer Med. 2023. PMID: 37096925 Free PMC article.
-
Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).Oncol Ther. 2018 Dec;6(2):189-201. doi: 10.1007/s40487-018-0065-7. Epub 2018 Oct 22. Oncol Ther. 2018. PMID: 32700029 Free PMC article.
-
Construction of gastric cancer patient-derived organoids and their utilization in a comparative study of clinically used paclitaxel nanoformulations.J Nanobiotechnology. 2022 May 18;20(1):233. doi: 10.1186/s12951-022-01431-8. J Nanobiotechnology. 2022. PMID: 35585597 Free PMC article.
-
Clinical characteristics and outcomes of cancer patients requiring intensive care unit admission: a prospective study.J Cancer Res Clin Oncol. 2018 Apr;144(4):717-723. doi: 10.1007/s00432-018-2581-0. Epub 2018 Jan 23. J Cancer Res Clin Oncol. 2018. PMID: 29362918 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical